Related Experiment Video
Updated: Jun 18, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Weight control program for obese pregnant women.
Elisabeth Storck Lindholm1, Margareta Norman, Charlotte Palme Kilander
1Division of Obstetrics and Gynecology, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden. elisabeth.lindholm@ds.se
Acta Obstetricia Et Gynecologica Scandinavica
|December 8, 2009
Summary
An intervention program helped obese women manage pregnancy weight gain. This dietary and physical activity approach resulted in healthy outcomes for mothers and babies.
Area of Science:
- Obstetrics and Gynecology
- Maternal Health
- Obesity in Pregnancy
Background:
- Obesity in pregnant women is linked to adverse maternal and fetal outcomes.
- Effective strategies are needed to manage excessive gestational weight gain in obese populations.
Purpose of the Study:
- To evaluate an intervention program for controlling pregnancy weight gain in obese women (BMI > 30).
- To assess the impact of the program on maternal weight gain and perinatal outcomes.
Main Methods:
- A cohort of 27 obese women participated in a structured dietary and physical activity intervention program.
- Maternal weight gain, incidence of hypertension and gestational diabetes, delivery mode, and infant Apgar scores were recorded.
Main Results:
- 25 out of 27 (92%) women completed the study.
- 14 women achieved the study weight goal of < or =6 kg weight gain.
- No cases of gestational diabetes were observed; 3 women experienced mild hypertension. All deliveries resulted in normal-sized babies with good Apgar scores.
Conclusions:
- An early intervention program incorporating diet and physical activity can effectively help obese women manage pregnancy weight gain.
- This approach appears safe, with no adverse perinatal outcomes observed.
Related Concept Videos
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...